Sort
30,917 grants matching “tumor microenvironment”
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease
$305,287Bonnie F Sloane · Wayne State University · R01 · FY2011 · CA
Clinical specimen tumor-TME acquired resistance
$305,261Trever G Bivona · University Of California, San Francisco · U54 · FY2023 · CA
A phase I trial to assess the safety and immunogenicity of repeated, cluster part
$305,192Ronald D. Alvarez · Johns Hopkins University · P50 · FY2011 · CA
Project 4- Targeting the neuronal microenvironment in gliomas (Monje/Suva)
$305,184Mario Luca Suva · Brigham And Women'S Hospital · P50 · FY2021 · CA
Akt Signaling Pathways in VEGF-A-induced Angiogenesis
$305,080Laura E Benjamin · Beth Israel Deaconess Medical Center · P01 · FY2011 · CA
Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme
$305,069Asish Kumar Ghosh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2017 · CA
Microvesicle Dynamics in B-Cell Chronic Lymphocytic Leukemia Tumor Microenvironme
$305,069Asish Kumar Ghosh · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2016 · CA
Regulation of T cell immunity by stromal cells in autoimmune tissue inflammation
$305,043Shannon J Turley · Dana-Farber Cancer Inst · P01 · FY2013 · AI
Role of and Epithelial Ets Factor in Breast Cancer
$305,030Dennis K Watson · Medical University Of South Carolina · P01 · FY2007 · CA
Mechanisms of resistance to cancer therapeutics
$305,025Lalita A. Shevde · University Of Alabama At Birmingham · R01 · FY2018 · CA
Mechanisms of resistance to cancer therapeutics
$305,025Lalita A. Shevde · University Of Alabama At Birmingham · R01 · FY2015 · CA
Mechanisms of resistance to cancer therapeutics
$305,025Lalita A. Shevde · University Of Alabama At Birmingham · R01 · FY2014 · CA
Mechanisms of resistance to cancer therapeutics
$305,025Lalita A. Shevde · University Of Alabama At Birmingham · R01 · FY2016 · CA
Mechanisms of resistance to cancer therapeutics
$305,025Lalita A. Shevde · University Of Alabama At Birmingham · R01 · FY2017 · CA
Role of Hypoxia in the regulation of cancer cell differentiation
$305,017Zhong Yun · Yale University · R01 · FY2011 · CA
Advancing Cancer Biology, Diagnostics and Therapeutics Outside of the Patient: Creation of a Novel, Autologous, Ex Vivo, Vascularized Model of the Tumor Microenvironment
$305,000Ryan C Fields · Washington University · R21 · FY2018 · CA
Neural Stem Cell Based Virotherapy for Malignant Glioma
$304,995Maciej S Lesniak · Northwestern University At Chicago · P50 · FY2025 · CA
Hypoxia and Gene Repression
$304,966Amato J. Giaccia · Stanford University · R37 · FY2013 · CA
IGF::OT::IGF SBIR Phase I Topic 357; POP: 09/11/2017 - 06/10/2018 The Office of Management and Budget has issued Memorandum M-11-32 and M-12-16. These memoranda establish a goal of 15-day accelerated
$304,961Jesus Delgado · Intelligent Optical Systems, Inc. · N43 · FY2017 · CA
MRI Characterization of Biological Risk of Ductal Carcinoma in Situ
$304,946Habibollah Rahbar · University Of Washington · R01 · FY2021 · CA
Hostile Environments Promote Invasion and Metastasis
$304,903Zaver M Bhujwalla · Johns Hopkins University · R01 · FY2022 · CA
Notch ligands in regulation of anti-cancer immunity
$304,831David P Carbone · Ohio State University · R01 · FY2014 · CA
The role of ERRalpha/PGC-1 in disease pathogenesis
$304,783Donald P McDonnell · Duke University · R01 · FY2014 · CA
In-situ activation of antitumor effectors
$304,774Edmund C. Lattime · Univ Of Med/Dent Nj-R W Johnson Med Sch · R01 · FY2011 · CA
Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the Chemoresistance of Neuroblasma
$304,728Muller Fabbri · Children'S Research Institute · R01 · FY2021 · CA